There’s an overall preference for long-acting injectable antiretroviral therapy among women with HIV, but various factors impact a patient’s preference. Learn more with this brief recap of an abstract that was presented at the 2024 Conference on Retroviruses and Opportunistic Infections.
Assessing Interest in Oral vs. LAI ART Among Women with HIV
Long-acting injectable (LAI) antiretroviral therapy (ART) represents a significant advancement in the management of HIV as these formulations can not only help improve outcomes, but also overcome several barriers associated with daily oral ART, such as adherence, privacy, and stigma. But despite these potential benefits, studies have revealed mixed feelings in terms of patients’ interest and acceptance. In fact, these feelings towards LAI ART may even differ by sex.
That’s why an abstract presented at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) sought to learn more about the various factors that might affect a patient’s preference for LAI versus oral ART.
In order to examine these factors and patient preferences, a cross-sectional survey was administered to 1,078 U.S. women with HIV between September 2020 and November 2021. This survey used a multinomial logistic regression method to assess and compare preferences based on age, race/ethnicity, income, education, adherence, and location.
Below are the demographic characteristics of the women who participated in the survey:
- The median age was 54
- 72 percent were Black and 13 percent were Hispanic
- 58 percent had an annual income of at least $12k
- 37 percent finished more than high school
- 88 percent reported at least 95 percent adherence to oral ART
- Locations included Atlanta, Birmingham, Jackson, Bronx, Brooklyn, Chapel Hill, Chicago, Miami, San Francisco, and Washington, D.C.
Overall, 43 percent of women preferred LAI ART, 36 percent preferred oral ART, and 21 percent were unsure.
Diving further into the results by examining patient preferences based on demographic characteristics, older women who reported high adherence to oral ART unsurprisingly preferred oral ART. Women in Miami also preferred oral ART whereas women in other cities preferred LAI ART.
Now when comparing women who preferred LAI ART versus those who were unsure, Hispanic women were more likely to prefer LAI ART. And comparing women who preferred oral ART versus those who were undecided, oral ART was preferred by women whose racial category was “other,” and LAI ART was preferred by women whose income was greater than or equal to $12k. Lastly, women in cities other than Miami were more likely to prefer LAI ART when compared to undecided women.
Based on these findings, researchers conclude that while about 20 percent remained unsure, there was an overall preference for LAI over oral ART, and these preferences were influenced by age, race/ethnicity, income, adherence, and location.
And so the researchers recommend tailoring education and support around LAI ART to ensure equitable access to treatment for all women with HIV, especially those who could potentially benefit from LAI ART based on their unique needs and experiences.
References:
Philbin MM, McCrimmon T, Collins LF, et al. Associations between interest in oral vs long-acting injectable art among US women with HIV - croi conference. CROI Conference. March 7, 2024. Accessed March 27, 2024. https://www.croiconference.org/abstract/associations-between-interest-in-oral-vs-long-acting-injectable-art-among-us-women-with-hiv/.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
There’s an overall preference for long-acting injectable antiretroviral therapy among women with HIV, but various factors impact a patient’s preference. Learn more with this brief recap of an abstract that was presented at the 2024 Conference on Retroviruses and Opportunistic Infections.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?